Defensin Therapeutics ApS

Defensin Therapeutics is a Danish biopharmaceutical company spun out from Novozymes A/S in 2013. Defensin Therapeutics focuses on the development and commercialization of novel products for the treatment of diseases and conditions associated with dysregulation of the human microbiota.

Address
Cobis
Ole Maaloesvej 3
DK-2200 - Copenhagen N
Denmark

Phone: +45 25471646
Email: pno@defensintherapeutics.com
Website: https://www.defensintherapeutics.com/

Contact

Name: Peter Nordkild, MD
Position: CEO